Article Details

Imugene (ASX:IMU) to initiate new trial after FDA IND approval paves way

Retrieved on: 2021-07-01 23:59:24

Tags for this article:

Click the tags to see associated articles and topics

Imugene (ASX:IMU) to initiate new trial after FDA IND approval paves way. View article details on hiswai:

Excerpt

Imugene (IMU) and the City of Hope can initiate a phase I clinical breast cancer study after receiving investigation new drug approval; The US Food ...

Article found on: themarketherald.com.au

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up